- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/00 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 5/00
Total number of patents in this class: 994
10-year publication summary
|
80
|
54
|
50
|
41
|
26
|
26
|
14
|
14
|
13
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19961 |
23 |
| Protagonist Therapeutics, Inc. | 136 |
10 |
| Centre National de La Recherche Scientifique | 10464 |
9 |
| Novartis AG | 10744 |
8 |
| Massachusetts Institute of Technology | 10062 |
8 |
| Northwestern University | 3398 |
8 |
| Bicyclerd Limited | 145 |
8 |
| The Johns Hopkins University | 5675 |
7 |
| Arrowhead Pharmaceuticals, Inc. | 303 |
7 |
| Onyx Therapeutics, Inc. | 69 |
7 |
| The University of British Columbia | 1495 |
7 |
| Wisconsin Alumni Research Foundation | 3894 |
6 |
| The General Hospital Corporation | 4740 |
6 |
| Adocia | 144 |
6 |
| Emulate, Inc. | 219 |
6 |
| Oncotherapy Science, Inc. | 269 |
6 |
| President and Fellows of Harvard College | 5986 |
5 |
| The Trustees of the University of Pennsylvania | 4323 |
5 |
| Purdue Research Foundation | 3629 |
5 |
| Academia Sinica | 940 |
5 |
| Other owners | 842 |